IRF8 has been identified as a tumor suppressor in AML, and when IRF8 is removed from mice the animals develop a spontaneous disease with similarities to human CML, including a transition to blast crisis in about a third of animals (74, 75). The gene discussed is IRF8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.